SCHEMBL3587423

SCHEMBL3587423

Nc1nc(-c2cccc3ccccc23)c2cn[nH]c2n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.55
ADORA1 P30542 1/20 0.55
HRH3 Q9Y5N1 1/20 0.42
DHFR P00374 2/20 0.42
MAPK1 P28482 1/20 0.39
ALDH1A1 P00352 1/20 0.39
PARP1 P09874 1/20 0.39
PRKCI P41743 1/20 0.39
PDE4B Q07343 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PI4KA P42356 1/20 0.38
PI4K2B Q8TCG2 1/20 0.38
PI4K2A Q9BTU6 1/20 0.38
PI4KB Q9UBF8 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
NOS1 P29475 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29761064 0.79 ADORA2A (0.51) ADORA2AADORA1CDK2
SCHEMBL30162646 0.78 ADORA2A (0.60) ADORA2AADORA1DHFRMAPK1ALDH1A1
SCHEMBL4459534 0.71 ADORA2A (1.00) ADORA2AADORA1DHFRALDH1A1HSD17B10
SCHEMBL21514162 0.69 METAP2 (0.66) MAPK1ALDH1A1PARP1PRKCIPDE4B
SCHEMBL5748987 0.69 DHFR (0.62) ADORA2AHRH3DHFRALDH1A1HSD17B10
SCHEMBL23388343 0.69 ADORA2A (0.61) ADORA2AADORA1PIK3CAMETAP2
Benzene SCHEMBL25427466 0.69 RET (0.52) ADORA2AADORA1DHFRMAPK1PI4KA
SCHEMBL29487078 0.68 XDH (0.55) ADORA2AADORA1DHFRALDH1A1TDP1
SCHEMBL1014920 0.68 XDH (0.55) ADORA2AADORA1DHFRALDH1A1TDP1
SCHEMBL10725446 0.67 ALDH1A1 (0.41) HRH3DHFRALDH1A1HSD17B10PI4KA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100190787-A1 Modulators of Mitotic Kinases BIOGEN IDEC MA INC 2010-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100190787-A1 Modulators of Mitotic Kinases CDK1, BUB1, BUB1B ADORA2A 4496/4885ADORA1 4010/4885HRH3 2673/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.